0.401
0.25%
+0.001
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
Brokers Set Expectations for Aethlon Medical, Inc.'s FY2024 Earnings (NASDAQ:AEMD) - Defense World
Defense World
Aethlon Medical sets $4.7 million public offering price By Investing.com - Investing.com
Investing.com
Is Aethlon Medical Inc (AEMD) positioned for future growth? – Sete News - SETE News
SETE News
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Pricing of $4.7 Million Public ... - Investorideas.com newswire
Investorideas.com newswire
Dow Jumps 200 Points; US Inflation Rate Slows In April - Aethlon Medical (NASDAQ:AEMD) - Benzinga
Benzinga
Aethlon Medical Inc (AEMD)'s stock price in review: A technical analysis – US Post News - US Post News
US Post News
Aethlon Medical Inc (AEMD) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
The InvestChronicle
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com - Defense World
Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Increase in Short Interest - Defense World
Defense World
What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday? - MSN
MSN
What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday? - Aethlon Medical (NASDAQ:AEMD) - Benzinga
Benzinga
Aethlon jumps on positive results from in vitro binding study of Hemopurifier device - Seeking Alpha
Seeking Alpha
Aethlon Medical Shares Double After Positive Results from Early Trial of Hemopurifier - MarketWatch
MarketWatch
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
Defense World
Aethlon Medical signs MTA for Santersus devices - Medical Device Network
Medical Device Network
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Aethlon - Benzinga
Benzinga
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy ... - PR Newswire
PR Newswire
Aethlon Medical receives approval in India for Hemopurifier trial - Medical Device Network
Medical Device Network
Aethlon Medical (NASDAQ: AEMD) to jump 1,000% - no, don’t, really - Dhaka Tribune
Dhaka Tribune
San Diego Biotech Company's Therapy Treatment Showing Promising Results in COVID Patients - NBC San Diego
NBC San Diego
Aethlon Quintuples as Hemopurifier Device Gets Reddit Attention - TheStreet
TheStreet
18 Medical Stocks To Watch Amid The Coronavirus Outbreak - Inovio Pharmaceuticals (NASDAQ:INO), Novavax ( - Benzinga
Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session - Abeona Therapeutics (NASDAQ:ABEO), Aethlon Medical (NASDA - Benzinga
Benzinga
Mid-Day Market Update: U.S. Stocks Turn Positive; Akcea Therapeutics Shares Jump - Aethlon Medical (NASDA - Benzinga
Benzinga
Aethlon Medical biz Exosome Science readies CTE biomarker trial of ex-NFL players - Mass Device
Mass Device
Aethlon Medical announces the conclusion of hemopurifier clinical study - Reuters
Reuters
Aethlon's blood filtration device as broad countermeasure for infectious diseases - Mass Device
Mass Device
Aethlon Medical (AEMD) Stock Price, News & Analysis - MarketBeat
MarketBeat
Aethlon Medical's Exosome Sciences Announces the Publication of Preliminary Findings of a Blood Test to Detect ... - PR Newswire
PR Newswire
Aethlon Medical Announces Ebola Humanitarian Use Device Submission To The FDA - Med Device Online
Med Device Online
Aethlon Medical Inc.: Total Scam Or Legit Company? (NASDAQ:AEMD) - Seeking Alpha
Seeking Alpha
Time Magazine Names The Aethlon Hemopurifier® One of the 25 Best Inventions of 2014 - PR Newswire
PR Newswire
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc. - PR Newswire
PR Newswire
Aethlon Medical Announces Launch of Exosome Sciences Subsidiary - PR Newswire
PR Newswire
Biotech/ Biodefense Sector Trading Alert - Aethlon Medical (NASDAQ:AEMD), Emergent BioSolutions (NYSE:EBS - Benzinga
Benzinga
RedChip Visibility Issues First Quarter Research Update On Aethlon Medical - GlobeNewswire
GlobeNewswire
Kapitalisierung:
|
Volumen (24h):